Uciechowski P, Gessner J E, Schindler R, Schmidt R E
Abteilung für Immunologie und Transfusionsmedizin, Medizinische Hochschule Hannover, FRG.
Eur J Immunol. 1992 Jun;22(6):1635-8. doi: 10.1002/eji.1830220643.
The transmembrane protein CD16 (Fc gamma RIII) is detected on activated macrophages, natural killer (NK) cells and a small subset of T lymphocytes. From CD3-CD56+ CD16+bright NK cells and CD3+ CD56+ CD16+dim non-major histocompatibility complex (MHC)-restricted cytotoxic T lymphocyte (CTL) clones were generated reflecting the stable, but different, CD16 expression of the respective peripheral blood subpopulations. To compare the role of CD16 on NK cells and non-MHC-restricted CTL, Fc gamma RIII activation and its mechanisms were investigated using monoclonal antibodies (mAb). Cross-linking of CD16 induced Ca2+ influx in CD16+bright NK clones. In contrast, there was no Ca2+ mobilization after CD16 activation in CD16+dim CTL, which revealed a good response to cross-linking of CD3 antigen. Pretreatment with CD16 mAb alone or cross-linked CD16 mAb did not block the CD3 response of CD16+dim CTL. Again, CD16 cross-linking induced more interferon-gamma transcription in NK cell clones than in non-MHC-restricted CTL clones. Also a higher tumor necrosis factor-alpha production of NK clones after CD16 cross-linking compared to CD16+dim CTL could be observed. These data suggest that after CD16 activation CD16+dim CTL and CD16+bright NK cells use different second messengers. In addition, signal transduction via CD3 and CD16 appears to function independently in CD16+dim non-MHC-restricted CTL.
跨膜蛋白CD16(FcγRIII)可在活化的巨噬细胞、自然杀伤(NK)细胞及一小部分T淋巴细胞上检测到。从CD3-CD56+CD16+bright的NK细胞以及CD3+CD56+CD16+dim的非主要组织相容性复合体(MHC)限制性细胞毒性T淋巴细胞(CTL)克隆中生成了反映各自外周血亚群稳定但不同的CD16表达情况。为比较CD16在NK细胞和非MHC限制性CTL上的作用,使用单克隆抗体(mAb)研究了FcγRIII的激活及其机制。CD16的交联诱导了CD16+bright NK克隆中的Ca2+内流。相比之下,CD16+dim CTL在CD16激活后没有Ca2+动员,但其对CD3抗原的交联显示出良好反应。单独用CD16 mAb或交联的CD16 mAb预处理并未阻断CD16+dim CTL的CD3反应。同样,CD16交联在NK细胞克隆中诱导的干扰素-γ转录比在非MHC限制性CTL克隆中更多。与CD16+dim CTL相比,还可观察到CD16交联后NK克隆中肿瘤坏死因子-α的产生更高。这些数据表明,CD16激活后,CD16+dim CTL和CD16+bright NK细胞使用不同的第二信使。此外,在CD16+dim非MHC限制性CTL中,经由CD3和CD16的信号转导似乎独立发挥作用。